Drug name - Vizamyl

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7351401 GE HEALTHCARE Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition
Jan, 2023

(3 months from now)

US8236282 GE HEALTHCARE Benzothiazole derivative compounds, compositions and uses
May, 2024

(1 year, 7 months from now)

US7270800 GE HEALTHCARE Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
Sep, 2025

(2 years from now)

CN1784392A GE HEALTHCARE Benzothiazole Derivative Compounds, Compositions And Use
Aug, 2012

(10 years ago)

CN1285582C GE HEALTHCARE For Diagnosis Of Presenile Dementia And Amyloid Deposition In Vivo Imaging And Prevention Of Sulfur Flavin Derivatives
Aug, 2021

(1 year, 1 month ago)

CN1535268A GE HEALTHCARE For Diagnosis Of Presenile Dementia And Amyloid Deposition In Vivo Imaging And Prevention Of Sulfur Flavin Derivatives
Aug, 2021

(1 year, 1 month ago)

CN102532055A GE HEALTHCARE Benzothiazole Derivative Compounds, Compositions And Uses Thereof
Mar, 2024

(1 year, 5 months from now)

CN102532055B GE HEALTHCARE Benzothiazole Derivative Compounds, Compositions And Use
Mar, 2024

(1 year, 5 months from now)

EP2264018A2 GE HEALTHCARE Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease
Aug, 2021

(1 year, 1 month ago)

EP1334091A2 GE HEALTHCARE Thioflavin Derivatives And Their Use In Diagnosis And Therapy Of Alzheimer'S Disease
Aug, 2021

(1 year, 1 month ago)

EP2264018B1 GE HEALTHCARE Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease
Aug, 2021

(1 year, 1 month ago)

EP1334091B1 GE HEALTHCARE Thioflavin Derivatives And Their Use In Diagnosis And Therapy Of Alzheimer'S Disease
Aug, 2021

(1 year, 1 month ago)

EP2264018A3 GE HEALTHCARE Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease
Aug, 2021

(1 year, 1 month ago)

EP1611115A1 GE HEALTHCARE Benzothiazole Derivative Compounds, Compositions And Uses
Mar, 2029

(6 years from now)

EP1611115B1 GE HEALTHCARE Benzothiazole Derivative Compounds, Compositions And Uses
Mar, 2029

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8691185 GE HEALTHCARE Benzothiazole derivative compounds, compositions and uses Jan, 2023

(3 months from now)

US8916131 GE HEALTHCARE Radiopharmaceutical composition Sep, 2028

(5 years from now)

Drugs and Companies using FLUTEMETAMOL F-18 ingredient

Treatment: Diagnostic radioimaging

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
40.5mCi/10ML (4.05mCi/ML) INJECTABLE;INTRAVENOUS Discontinued
121.5mCi/30ML (4.05mCi/ML) INJECTABLE;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.